Adaptive Biotechnologies Corporation
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2017 | 59.2% | -115.7% | -111.4% |
| FY2018 | 64.7% | -89.4% | -83.4% |
| FY2019 | 73.8% | -92.1% | -80.6% |
| FY2020 | 77.1% | -155.3% | -148.6% |
| FY2021 | 68.1% | -135.4% | -134.3% |
| FY2022 | 68.7% | -108.0% | -108.0% |
| FY2023 | 55.6% | -133.3% | -132.3% |
| FY2024 | 59.7% | -90.8% | -89.1% |
| FY2025 | 74.2% | -20.6% | -21.5% |